Pseudoprogression of Glioblastoma after Chemo- and Radiation Therapy: Diagnosis by Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging with Ferumoxytol versus Gadoteridol and Correlation with Survival.
Radiology., Nov (2012)
A 67 year old woman on tumor necrosis factor- alpha inhibitor therapy presenting with neurological dysfunction.
Arthritis Care Res (Hoboken)., Nov (2012)
The effect of alpha-v integrin inhibition on the malignant characteristics of medulloblastoma.
J Neurosurg Pediatr., Oct (2012)
Immunologic privilege in the central nervous system and the blood-brain barrier.
J. Cereb. Blood Flow Metab., Oct (2012)
Ferumoxytol-enhanced MRI to Image Inflammation within Human Brain Arteriovenous Malformations: A Pilot Investigation.
Transl Stroke Res., Jul;3(Supplement 1):166-173 (2012)
Targeting Î±V-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model.
J. Neurooncol., Oct;110(1):27-36 (2012)
Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.
J. Clin. Oncol., Jul;30(19):2408-17 (2012)
Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors.
J. Neurooncol., Aug;109(1):105-14 (2012)
Cerebrospinal fluid shunting and hearing loss in patients treated for medulloblastoma.
J Neurosurg Pediatr., Apr;9(4):421-7 (2012)
Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.
AJR Am J Roentgenol., Oct;197(4):981-8 (2011)
Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol.
Radiology., Dec;261(3):796-804 (2011)
Late occurrence of drop metastasis to the spine in a case of esthesioneuroblastoma.
J Neurosurg Spine., Nov;15(5):571-5 (2011)
MRI using ferumoxytol improves the visualization of central nervous system vascular malformations.
Stroke., Jun;42(6):1581-8 (2011)
Imaging and therapy with rituximab anti-CD20 immunotherapy in an animal model of central nervous system lymphoma.
Clin. Cancer Res., Apr;17(8):2207-15 (2011)
Engaging neuroscience to advance translational research in brain barrier biology.
Nat. Rev. Neurosci., Mar;12(3):169-82 (2011)
The paradoxical effect of bevacizumab in the therapy of malignant gliomas.
Neurology., Jan;76(1):87-93 (2011)
Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol.
Neuro-oncology., Feb;13(2):251-60 (2011)
Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models.
Neuro-oncology., Jan;13(1):51-60 (2011)
Temozolomide for corticotroph pituitary adenomas refractory to standard therapy.
Pituitary., Mar;14(1):80-91 (2011)
Correlation of MRI sequences to assess progressive glioblastoma multiforme treated with bevacizumab.
J. Neurooncol., Jun;103(2):353-60 (2011)